MDWD
Price
$21.60
Change
-$0.07 (-0.32%)
Updated
Jun 6 closing price
Capitalization
233.45M
66 days until earnings call
PHIO
Price
$2.96
Change
+$0.50 (+20.33%)
Updated
Jun 6 closing price
Capitalization
14.2M
Interact to see
Advertisement

MDWD vs PHIO

Header iconMDWD vs PHIO Comparison
Open Charts MDWD vs PHIOBanner chart's image
MediWound
Price$21.60
Change-$0.07 (-0.32%)
Volume$40.15K
Capitalization233.45M
Phio Pharmaceuticals
Price$2.96
Change+$0.50 (+20.33%)
Volume$2.07M
Capitalization14.2M
MDWD vs PHIO Comparison Chart
Loading...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDWD vs. PHIO commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDWD is a Buy and PHIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (MDWD: $21.60 vs. PHIO: $2.96)
Brand notoriety: MDWD and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDWD: 56% vs. PHIO: 47%
Market capitalization -- MDWD: $233.45M vs. PHIO: $14.2M
MDWD [@Biotechnology] is valued at $233.45M. PHIO’s [@Biotechnology] market capitalization is $14.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDWD’s FA Score shows that 1 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • MDWD’s FA Score: 1 green, 4 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, MDWD is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDWD’s TA Score shows that 4 TA indicator(s) are bullish while PHIO’s TA Score has 4 bullish TA indicator(s).

  • MDWD’s TA Score: 4 bullish, 5 bearish.
  • PHIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than MDWD.

Price Growth

MDWD (@Biotechnology) experienced а -1.64% price change this week, while PHIO (@Biotechnology) price change was +48.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

MDWD is expected to report earnings on Aug 12, 2025.

PHIO is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDWD($233M) has a higher market cap than PHIO($14.2M). PHIO YTD gains are higher at: 64.444 vs. MDWD (21.348). MDWD has higher annual earnings (EBITDA): -6.58M vs. PHIO (-7.41M). MDWD has more cash in the bank: 45.6M vs. PHIO (5.39M). PHIO has less debt than MDWD: PHIO (0) vs MDWD (6.46M). MDWD has higher revenues than PHIO: MDWD (19.7M) vs PHIO (0).
MDWDPHIOMDWD / PHIO
Capitalization233M14.2M1,641%
EBITDA-6.58M-7.41M89%
Gain YTD21.34864.44433%
P/E RatioN/A0.01-
Revenue19.7M0-
Total Cash45.6M5.39M846%
Total Debt6.46M0-
FUNDAMENTALS RATINGS
MDWD vs PHIO: Fundamental Ratings
MDWD
PHIO
OUTLOOK RATING
1..100
2531
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
3938
P/E GROWTH RATING
1..100
366
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHIO's Valuation (58) in the Biotechnology industry is in the same range as MDWD (68) in the Pharmaceuticals Other industry. This means that PHIO’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's Profit vs Risk Rating (78) in the Pharmaceuticals Other industry is in the same range as PHIO (100) in the Biotechnology industry. This means that MDWD’s stock grew similarly to PHIO’s over the last 12 months.

MDWD's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as PHIO (96) in the Biotechnology industry. This means that MDWD’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's Price Growth Rating (38) in the Biotechnology industry is in the same range as MDWD (39) in the Pharmaceuticals Other industry. This means that PHIO’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's P/E Growth Rating (3) in the Pharmaceuticals Other industry is somewhat better than the same rating for PHIO (66) in the Biotechnology industry. This means that MDWD’s stock grew somewhat faster than PHIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDWDPHIO
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCERX27.32N/A
N/A
Columbia Large Cap Enhanced Core R
GOGFX38.07N/A
N/A
Victory Sycamore Small Company Opp R
IFPUX20.71N/A
N/A
Independent Franchise Partners US Equity
TSGMX15.85N/A
N/A
Transamerica Sustainable Growth Eq R6
DFRSX18.28-0.09
-0.49%
DFA Asia Pacific Small Company I

MDWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDWD has been loosely correlated with PHIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MDWD jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
-0.32%
PHIO - MDWD
35%
Loosely correlated
+20.33%
AKRO - MDWD
33%
Poorly correlated
+0.63%
INSM - MDWD
32%
Poorly correlated
+1.21%
KANT - MDWD
30%
Poorly correlated
+8.49%
VCEL - MDWD
27%
Poorly correlated
-0.23%
More

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
+20.33%
MTNB - PHIO
50%
Loosely correlated
+6.01%
TPST - PHIO
49%
Loosely correlated
+3.85%
SAGE - PHIO
42%
Loosely correlated
+1.03%
IMNN - PHIO
39%
Loosely correlated
+4.29%
SLRX - PHIO
36%
Loosely correlated
-4.12%
More